As a member of US Oncology Research, Arizona Oncology is pleased to provide local patients access to cutting-edge and innovative clinical trials in a comfortable and convenient setting. US Oncology Research, supported by McKesson Specialty Health, recently announced that it has surpassed the 50,000 milestone for patients enrolled in its clinical trials program.
One of the largest and most reputable community-based research networks in the world, US Oncology Research specializes in Phase I–IV oncology clinical trials and has participated in over 1,200 investigator-initiated and sponsor-initiated trials since its inception. The program brings innovative therapies and clinical trials to practices and patients in communities across the nation to help advance the science of cancer care while offering the best possible treatments and improved patient outcomes.
Clinical Trials at Arizona Oncology
At Arizona Oncology, we are at the forefront of cancer research and offer participation in clinical trials for many different types of cancer. We believe it is important to provide access to promising new therapies and treatment options to patients in our community. These trials also give many of our patients the opportunity to receive newly developed treatments or investigational drugs not yet available outside the study.
